Introduction
Breast cancer is the commonest malignancy to affect women in the western nations and accounts for 14,000 deaths in the United Kingdom and 40,000 in America each year. There are two main types of breast cancer, the sporadic variety which accounts for 90% of patients and the familial type which accounts for the remaining 10%. Of all the risk factors known to be associated with developing breast cancer, the one with the most predictability is a positive family history of the disease. Because of the greater patient awareness of the importance of a positive family history, familial breast cancer will assume greater clinical importance than in the past. This review will elucidate the features of familial breast cancer that separate it from the sporadic variety of the disease and denotes the risk for developing breast cancer.
Definition
Familial breast cancer is defined as the occurrence of two of more first degree relatives in the nuclear pedigree including the proband. 
Improved survival
In one study the five year disease-free survival rate was found to be 66% in the hereditary form of the disease, which was significantly better than the 42% survival in the American College of Surgeons (A.C.S.) Register Study.'2 It remains obscure why this should be so, but it was not felt that earlier diagnosis was a factor or that the patients were on average younger than the comparable A.C.S. Tumour Registry patients.
Lack of a protective effect of pregnancy at an early age A pregnancy at an early age is believed to have a protective effect in the sporadic form of breast cancer, but this has been shown not to be the case in familial breast cancer. 13 What is the importance of familial breast cancer? This is a question of critical importance and is best answered by stating the risk of developing the disease. Anderson showed significant variation in breast cancer risk to first degree relatives of cancer group.bmj.com on October 14, 2017 -Published by http://pmj.bmj.com/ Downloaded from probands.14 Specifically he compared breast cancer patients who had a family history of breast cancer with controls consisting of cancer patients with family histories of malignant neoplasms arising in sites other than the breast. He concluded that first degree relatives of breast cancer patients manifest a two-to three-fold increased risk of developing breast cancer. When the disease in the patient was bilateral the risk for the relatives was five-fold and if the disease was both premenopausal and bilateral the risk was increased nine-fold. No increased risk was observed for relatives of patients with a postmenopausal diagnosis.
In a further study Schwartz estimated the cumulative risk of breast cancer before the age of 50 to be 1% for relatives of controls, 3% for sisters of older cases, but 17% for women with sisters diagnosed before the age of 40 years or with an affected sister and mother. Sisters of older patients had a 15% risk of breast cancer by the age of 70 years compared to sisters of controls, who had a risk of 5%. Women with an affected mother and sister had a 50% chance of developing the disease by the age of 65. 15 In other studies the estimated life time risk of an offspring of patients with familial breast cancer developing breast cancer or another associated malignancy was approximately 50% in females and 42% in males. 16 From these figures it would appear that identifying the familial form of the disease is of importance for the specific family and also has important implications for populaton screening for other cancers. Finally, Lynch studied 328 patients and showed that a more intensive family history documentation in patients about doubles the familial category.'7 This would strongly suggest an underestimation of the magnitude of the host factor component in breast cancer aetiology.
Conclusion
The risk of breast cancer to women with a family history of this disease remains a concern for breast cancer patients, their relatives and clinicians. Women with a positive family often ask what their risk is of developing the disease. The figures are available but more importantly the risk of developing cancer extends to other forms of cancer, especially colonic. At present risk can only be inferred from a personal history as no biological or genetic marker has been identified that will in turn identify women at increased risk.
